GENSCRIPT BIOTECH CORPORATION
(HKEX: 1548)

Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products. The Bio-science Services and Products segment includes life sciences research services, life sciences research catalogue products, and preclinical drug development services. The Precision Immune-cell Therapy segment discovers and develops therapies for the treatment of liquid tumour through optimised CAR structures and the development of bispecific CAR-T therapies. The Industrial Synthetic Biology Products segment comprises of the construction of non-pathogenic microbial strains and industrial enzyme development and production. The company was founded by Fang Liang Zhang, Lu Quan Wang, and Ye Wang in 2002 and is headquartered in Nanjing, China.

14.760 -

+0.260 (+1.79%)
Range 14.650 - 15.360   (4.85%)
Open 15.290
Previous Close 14.500
Bid Price 14.750
Bid Volume ('000) 54
Ask Price 14.760
Ask Volume ('000) 82
Volume ('000) 13,514.2
Value 201,936,102
Remark -
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis